SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950116-03-001945
Filing Date
2003-03-17
Accepted
2003-03-17 12:33:00
Documents
3
Period of Report
2003-03-17

Document Format Files

Seq Description Document Type Size
1 FORM4.HTM form4.htm 4 26470
3 GRAPHIC emptybox.gif GRAPHIC 1218
4 GRAPHIC tickedbox.gif GRAPHIC 1267
  Complete submission text file 0000950116-03-001945.txt   31136
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Subject) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 03605375
SIC: 2834 Pharmaceutical Preparations

Mailing Address 33 HARBOUR SQUARE STE 202 TORONTO ONTARIO CANA A6 M5J2G2
Business Address 33 HARBOR SQUARE STE 202 TORONTO ONTARIO CANA A6 M5J2G2 4164932594
HAWKE MICHAEL (Reporting) CIK: 0001189830 (see all company filings)